european medicines agency news

AstraZeneca, european medicines agency and lung cancer

AstraZeneca withdraws application for lung cancer drug in EU

AstraZeneca has voluntarily withdrawn its marketing authorisation application with the EU's medicines regulator for its experimental precision drug for the treatment of a type of lung cancer, it said on Tuesday.

Seeking Alpha on MSN · 17h

AstraZeneca, Daiichi pull EU marketing application for lung cancer drug, Dato-DXd

AstraZeneca (AZN) and Daiichi Sankyo (DSNKY) withdraw EU marketing application for lung cancer therapy Dato-DXd. Read more here.

Business Insider · 21h

AstraZeneca And Daiichi Sankyo Withdraw EU Marketing Application For Datopotamab Deruxtecan

British drug maker AstraZeneca Plc (AZN.L, AZN) and Daiichi Sankyo (DSKYF.PK) said that they have voluntarily withdrawn their

MarketWatch · 22h

AstraZeneca, Daiichi Sankyo Withdraw Authorization Application for Lung Cancer Treatment in EU

AstraZeneca said it and Daiichi Sankyo decided to voluntarily withdraw the marketing authorization application in the European Union for advanced lung-cancer treatment Dato-DXd. This decision followed a feedback from the European Medicines Agency,

21hon MSN

European markets close higher ahead of Christmas shutdown; Novo Nordisk resumes recovery

European markets are set to open higher on Tuesday, in a shortened trading session for Christmas Eve. London's FTSE 100 is ...

19h

European Shares Edge Higher Ahead Of Christmas Break

European stocks edged higher in cautious trade on Tuesday ahead of Christmas break. The German DAX is not trading today while the ...

The Wall Street Journal on MSN8d

GSK’s Cancer Drug Jemperli Moves a Step Closer to European Marketing Permission

In one of the final steps before a marketing authorization decision by the European Medicines Agency, it recommended ...

Danish agency seeks probe as Ozempic study shows link to vision loss

The Danish Medicines Agency said it would ask European authorities to review two new studies that point to a link between ...

MarketWatch11d

Gilead Gets Key European Backing for Liver-Disease Treatment

The biopharmaceutical company Friday said the recommendation by the European Medicines Agency's Committee for Medicinal Products for Human Use covers seladelpar in combination with ...

12d

Novo Nordisk's Ozempic Label Expansion Snags Approval From European Drug Regulator's Advisory Panel

Novo Nordisk's Ozempic gains positive EMA opinion for label update after FLOW trial data show significant kidney and ...

조선일보9d

Celltrion secures European approval recommendation for four biosimilars

Celltrion secures European approval recommendation for four biosimilars Celltrion advances its global strategy with a ...

11d

Merck & Co. Gets Key European Backing for Welireg in Two Uses

Merck & Co. said a key European regulatory committee has recommended conditional approval of its Welireg oral cancer drug in a pair of indications.

22h

AstraZeneca Withdraws EU Application for Lung Cancer Drug

AstraZeneca ( (GB:AZN) ) has shared an update. AstraZeneca and Daiichi Sankyo have withdrawn their EU marketing application for datopotamab deruxtecan for advanced nonsquamous non-small cell lung ...

Hosted on MSN11h

BMY Gets EC Nod for Opdivo Plus Yervoy in First-Line Colorectal Cancer

Bristol Myers Squibb BMY announced that the European Commission has approved the combination of its blockbuster ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results